The majority of therapeutic studies targeting amyloid, Although the effectiveness of most tau-targeted drugs has not been fully evaluated, this has led to a greater understanding of the complexities of AD and attempts to explore new drug mechanisms. The gene discussed is MAPT; the disease is Alzheimer disease.